Nov 26,2021

From imitation to innovation, domestic innovative drugs welcome the golden development period

Since January 1, 2021, the results of centralized procurement of coronary stents organized by the state have been implemented in many places, and the average price of coronary stents has dropped from about 13,000 yuan to about 700 yuan. According to the preset national reporting volume, 11.7 billion yuan will be saved throughout the year.

See more+

Nov 26,2021

Drug R&D entered the "golden age"

In 2020, the reform of China's drug evaluation and approval system will enter the fifth year.

See more+

Oct 06,2014

Eight biological products will be more strictly controlled next year

It was learned from the State Food and Drug Administration that from January 1 next year, China will implement the batch issuance system for eight kinds of biological products, including human serum albumin, recombinant hepatitis B vaccine, live attenuated measles vaccine, BCG vaccine, live attenuated oral polio vaccine, adsorbed pertussis, diphtheria and tetanus vaccine. According to relevant sources, this is an important step for China's biological product management standards to be in line with international standards.

See more+

Oct 06,2014

The development momentum of biotechnology in China is like a rainbow

With the rapid development of science and technology, the market for bioengineering and new drugs is extremely active. Especially in the past few years, when China has gradually integrated with the world pharmaceutical market, the biomedical industry has risen rapidly. Under the speculation of the stock market, the manufacturing industry, which is dominated by chemical drugs, is rapidly approaching the products of bioengineering technology. Today, with the slow development of chemical innovative drugs, the globalization of bioengineered drugs has become increasingly prominent, and has attracted more attention.

See more+

Oct 06,2014

Chinese Medicine: Patent Dilemma under the "Imitation" System

As the third year after joining the WTO, some people call this year the beginning of the "post WTO transition period". After the running in period of the first two years, the deep-seated problems in China's integration with the world are gradually emerging, among which intellectual property rights have gradually become the inevitable focus.

See more+

Oct 06,2014

International medical personnel remind the residents of the disaster area to guard against tetanus

JAKARTA, JANUARY 15 (Reporter Wu Qiang and Yu Qianliang) The international medical rescue organization "Doctors Without Borders" reminded residents of the disaster area in Aceh, Indonesia, on the 15th to be cautious of catching tetanus when clearing the ruins.

See more+

< 123 >

Contact us

Add:

Jinggangshan Economic and Technological Development Zone, Ji'an, Jiangxi, P.R.China.

Pharmacovigilance collection mailbox:

Pharmacovigilance telephone:

二维码

Microofficial website

二维码

WeChat


© Copyright 2022 Jiangxi Institute of Biological Products Inc.

Powered by www.300.cn​  SEO